Trial Of Setmelanotide (RM-493) For Patients Who Have Completed A Trial Of Setmelanotide For The Treatment Of Obesity (H-47510)

Long Term Extension Trial Of Setmelanotide (RM-493) For Patients Who Have Completed A Trial Of Setmelanotide For The Treatment Of Obesity Associated With Genetic Defects Upstream Of The MC4 Receptor In The Leptin-Melanocortin Pathway

This is a long-term extension study to study the safety and tolerability of continued Setmelanotide treatment in patients who have completed a previous clinical study on treatment with Setmelanotide for obesity associated with genetic defects upstream of the MC4 receptor in the leptin-melanocortin pathway.